Lactic Acid

Lactic Acid

SCHEMBL4626495

CC(C)CC(O)C(=O)O.CC(O)C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.58
RNPEP Q9H4A4 1/20 0.48
SLC7A5 Q01650 1/20 0.48
OR51E2 Q9H255 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
CPA1 P15085 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
TET2 Q6N021 3/20 0.39
KDM4A O75164 2/20 0.39
KDM4C Q9H3R0 2/20 0.39
KDM2A Q9Y2K7 2/20 0.39
TET3 O43151 1/20 0.39
GPR84 Q9NQS5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1336542 0.95
SCHEMBL28064758 0.95 RNPEP (0.52) TP53RNPEPSLC7A5OR51E2SMN1; SMN2
SCHEMBL185354 0.95
SCHEMBL361589 0.95
Methane SCHEMBL11205299 0.92 RNPEP (0.50) TP53RNPEPSLC7A5OR51E2SMN1; SMN2
Hydrochloric Acid SCHEMBL3345131 0.92 RNPEP (0.50) TP53RNPEPSLC7A5OR51E2SMN1; SMN2
SCHEMBL28300024 0.92 RNPEP (0.50) TP53RNPEPSLC7A5OR51E2SMN1; SMN2
SCHEMBL11476606 0.92 RNPEP (0.50) TP53RNPEPSLC7A5OR51E2SMN1; SMN2
Leucine SCHEMBL20898433 0.81 SLC7A5 (0.78) RNPEPSLC7A5SLC1A3SLC1A2
SCHEMBL30970939 0.80 TET2 (0.71) RNPEPSLC7A5TET2KDM4AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1281766-B1 Process for producing polyester, process for producing substituted alpha-hydroxy acid, and Clostridium beijerinckii strain HICA432 CANON KK (JP) 2008-06-04 EP disclosed
US-7273734-B2 Process for producing a polyester CANON KABUSHIKI KAISHA (JP) 2007-09-25 US disclosed
US-20050143574-A1 Process for producing a polyester CANON KABUSHIKI KAISHA (JP) 2005-06-30 US disclosed
US-20030027294-A1 Process for producing polyester, process for producing substituted a-hydroxy acid, and clostridium beijerinckii strain hica432 CANON KABUSHIKI KAISHA (JP) 2003-02-06 US disclosed
EP-1281766-A2 Process for producing polyester, process for producing substituted alpha-hydroxy acid, and Clostridium beijerinckii strain HICA432 CANON KABUSHIKI KAISHA (JP) 2003-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143574-A1 Process for producing a polyester CYP8B1, HSD11B1, HPD TP53 4550/4885RNPEP 1716/4885SLC7A5 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.